NEWS WRAP: Hong Kong IPO market crescendos with six new listings in one day
All six stocks closed up on their first trading day, as the group collectively raised $810 million By Doug Young Six companies made their trading debut on the Hong…
BRIEF: InSilico gets CSRC nod for Hong Kong IPO
AI drug discovery platform InSilico Medicine Cayman TopCo has been approved by China’s securities watchdog for a Hong Kong IPO, clearing a key hurdle in its stalled listing. According to…
AI drugs researcher QuantumPharm makes market debut on long road to profit
The newly floated biotech can boast big-name backers and counts more than a dozen biopharma heavyweights among its customers, but it is still awash with red ink Key Takeaways: QuantumPharm’s…
RELATED ARTICLES
-
Policy forces shift offshore Chinese IPO tide to Hong Kong from New York
- U.S. tries ‘monkey scaring’ to rid Wall Street of suspicious Chinese listings
- 15th Five-Year Plan: Who is leading offshore listings?
- Zeekr drives off Wall Street, heralding chilly year ahead for U.S. Chinese listings
- Move over, Hong Kong. Young Beijing Exchange becomes China’s new IPO hub
